Hemplab Institute
0649.743.810 · rovalta.com · 25/09/2026
ACTIVE
Hemplab Institute
Financial year 2025 · Closed on 31/12/2025
Net result-1,4 k €+50,6 %over 1 year
Gross margin-1,3 k €+38,6 %over 1 year
Equity-147 k €-1,0 %over 1 year
Overview
Identity
Source · BCE/KBOHemplab Institute is a Private limited company incorporated in 2016. Its registered office is in Niel.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0649.743.810
- Incorporation
- 08/03/2016
- Legal form
- Private limited company
- Registered office
- Galileilaan 15
2845 Niel · FlandreSee on map - Contributed capital
- 81 933,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 9 filingsTrend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -1,3 k € | +38.6% | -2,1 k € | +82.0% | -11,8 k € | +22.5% | -15,3 k € | +41.2% | -25,9 k € |
| EBITDA | -1,3 k € | +55.5% | -2,9 k € | +95.4% | -64,1 k € | -241% | -18,8 k € | +38.7% | -30,7 k € |
| Operating result | -1,3 k € | +55.5% | -2,9 k € | +95.4% | -64,1 k € | -97.8% | -32,4 k € | +34.4% | -49,4 k € |
| Net result | -1,4 k € | +50.6% | -2,9 k € | +94.2% | -50,7 k € | -52.3% | -33,3 k € | +34.4% | -50,7 k € |
| Balance sheet | |||||||||
| Equity | -147 k € | -1.0% | -145,5 k € | -2.1% | -142,6 k € | -55.2% | -91,9 k € | -56.8% | -58,6 k € |
| Total assets | 963,3 € | -3.1% | 994,6 € | -75.7% | 4,1 k € | -93.9% | 66,7 k € | -33.6% | 100,5 k € |
| Cash | – | 31,3 € | -90.4% | 328 € | -3.9% | 341,4 € | -75.5% | 1,4 k € | |
| Debts | 148 k € | +1.0% | 146,5 k € | -0.1% | 146,7 k € | -7.5% | 158,7 k € | -0.3% | 159,1 k € |
Board of directors
Source · NBB, accounts to 31/12/20251 active · 6 ended
Active mandates
Spiridon Michalopoulos
ActiveEnded mandates
Alexandros Nikolian
EndedAlexandros Nikolian
EndedGaston Kanaroglou Konstantinos
EndedKostas Kanaroglou
EndedOther companies at this address
Galileilaan 15 2845 Niel| Company | CBE no. |
|---|---|
4VISO● Active | 1027.105.086 |
ADM● Active | 0463.498.167 |
BMCDENIS● Active | 0834.200.394 |
BRIGHTSPEC● Active | 0846.102.393 |
CAST4ALL● Active | 0469.659.053 |
CIRCLAIR● Active | 1017.358.665 |
CosProf Studio● Active | 1011.646.553 |
| 0692.724.114 | |
FiriX Therapeutics● Active | 1024.780.848 |
GRAND MEDICAL (EUROPE)● Active | 0766.800.440 |
KARDECO● Active | 0427.600.348 |
| 0732.572.407 | |
MOBILAR● Active | 0779.489.327 |
NSX● Active | 0840.966.838 |
ORYX GROUP● Bankrupt | 0835.298.771 |
ORYX IT SERVICES● Bankrupt | 0835.842.565 |
OXYPOINT● Bankrupt | 0832.604.943 |
SIMMOCON● Active | 0786.692.269 |
Sodecon● Active | 0678.753.243 |
UBIS● Active | 0546.545.708 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 24/07/2026 | 04/07/2025 | 28/06/2024 | 05/07/2023 | 23/08/2022 | 27/10/2021 |
| General meeting | 05/06/2026 | 27/06/2025 | 07/06/2024 | 02/06/2023 | 03/06/2022 | 04/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 9 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 05/06/2026 | 24/07/2026 | Dutch | |
| Micro model | 31/12/2024 | 27/06/2025 | 04/07/2025 | Dutch | |
| Micro model | 31/12/2023 | 07/06/2024 | 28/06/2024 | Dutch | |
| Micro model | 31/12/2022 | 02/06/2023 | 05/07/2023 | Dutch | |
| Micro model | 31/12/2021 | 03/06/2022 | 23/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 04/06/2021 | 27/10/2021 | Dutch | |
| Micro model | 31/12/2019 | 08/09/2020 | 29/10/2020 | Dutch | |
| Micro model | 31/12/2018 | 07/06/2019 | 26/06/2019 | Dutch | |
| Micro model | 31/12/2017 | 01/06/2018 | 27/12/2018 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 6 ended
Active mandates
Spiridon Michalopoulos
ActiveEnded mandates
Alexandros Nikolian
EndedAlexandros Nikolian
EndedGaston Kanaroglou Konstantinos
EndedKostas Kanaroglou
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-1,4 k €↑
- 2024Annual accounts 2024-2,9 k €↑
- 2023Annual accounts 2023-50,7 k €↓
- 2022Annual accounts 2022-33,3 k €↑
- 2021Annual accounts 2021-50,7 k €↑
- 2020Annual accounts 2020-68,3 k €↓
- 2019Annual accounts 2019-2,2 k €↓
- 2018Annual accounts 20189,2 k €↑
- 2017Annual accounts 2017-28,5 k €
- 08/03/2016IncorporationPrivate limited company